QPW
KRYS icon

Quantum Private Wealth’s Krystal Biotech KRYS Stock Holding History

Quantum Private Wealth’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Hold
7,181
– – 0.57% 38
2025
Q4 		$1.77M Sell
7,181
-24
-0.3% -$5.05K 0.52% 38
2025
Q3 		$1.27M Hold
7,205
– – 0.37% 54
2025
Q2 		$990K Hold
7,205
– – 0.32% 56
2025
Q1 		$1.3M Hold
7,205
– – 0.49% 40
2024
Q4 		$1.13M Hold
7,205
– – 0.36% 54
2024
Q3 		$1.31M Hold
7,205
– – 0.44% 46
2024
Q2 		$1.32M Hold
7,205
– – 0.47% 43
2024
Q1 		$1.28M Hold
7,205
– – 0.47% 46
2023
Q4 		$894K Hold
7,205
– – 0.37% 64
2023
Q3 		$836K Hold
7,205
– – 0.4% 53
2023
Q2 		$846K Hold
7,205
– – 0.39% 61
2023
Q1 		$577K Hold
7,205
– – 0.31% 78
2022
Q4 		$571K Hold
7,205
– – 0.36% 74
2022
Q3 		$502K Buy
7,205
+1,000
+16% +$72.2K 0.31% 85
2022
Q2 		$407K Sell
6,205
-177
-3% -$11K 0.24% 98
2022
Q1 		$424K Sell
6,382
-442
-6% -$27.6K 0.18% 114
2021
Q4 		$477K Buy
+6,824
New +$397K 0.18% 116

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantum Private Wealth's KRYS Position: Q1 2026 in Review

Quantum Private Wealth held its Krystal Biotech (KRYS) position steady in Q1 2026 at 7,181 shares worth $1.85M. The position accounts for 0.57% of the portfolio, ranked #38.

Quantum Private Wealth first reported a position in KRYS in Q4 2021 and has held it in 18 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Quantum Private Wealth held 7,181 shares of Krystal Biotech worth $1.85M as of Q1 2026.
  • Quantum Private Wealth left its Krystal Biotech share count unchanged in Q1 2026.
  • Krystal Biotech made up 0.57% of Quantum Private Wealth's portfolio in Q1 2026, its #38 holding.
  • Quantum Private Wealth first reported a position in Krystal Biotech in Q4 2021 and has held it in 18 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Quantum Private Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.